C Adithan

1.6k total citations
74 papers, 1.2k citations indexed

About

C Adithan is a scholar working on Pharmacology, Molecular Biology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, C Adithan has authored 74 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Pharmacology, 15 papers in Molecular Biology and 15 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in C Adithan's work include Pharmacogenetics and Drug Metabolism (17 papers), Heart Rate Variability and Autonomic Control (7 papers) and Pharmacological Effects and Toxicity Studies (7 papers). C Adithan is often cited by papers focused on Pharmacogenetics and Drug Metabolism (17 papers), Heart Rate Variability and Autonomic Control (7 papers) and Pharmacological Effects and Toxicity Studies (7 papers). C Adithan collaborates with scholars based in India, France and Germany. C Adithan's co-authors include Sandhiya Selvarajan, Suresh Chandra Pradhan, C. H. Shashindran, Pravati Pal, R. V. Krishnamoorthy, G K Pal, Nathalie Gérard, Nivedita Nanda, S. Gopalakrishnan and Tarun Kumar Dutta and has published in prestigious journals such as SHILAP Revista de lepidopterología, European Journal of Cancer and Clinica Chimica Acta.

In The Last Decade

C Adithan

70 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C Adithan India 20 309 269 194 178 166 74 1.2k
Caterina Palleria Italy 21 158 0.5× 255 0.9× 224 1.2× 126 0.7× 141 0.8× 75 1.5k
Robert Z. Harris United States 19 401 1.3× 313 1.2× 200 1.0× 131 0.7× 66 0.4× 28 1.6k
Wan Gyoon Shin South Korea 20 188 0.6× 211 0.8× 197 1.0× 64 0.4× 87 0.5× 62 1.2k
Ayman Al‐Shurbaji Sweden 14 344 1.1× 289 1.1× 96 0.5× 109 0.6× 93 0.6× 32 1.0k
Barbara Ameer United States 20 547 1.8× 249 0.9× 216 1.1× 135 0.8× 160 1.0× 42 1.9k
Jacqueline B. McCrea United States 26 311 1.0× 184 0.7× 188 1.0× 146 0.8× 299 1.8× 77 2.0k
Helle R. Angelo Denmark 19 288 0.9× 174 0.6× 207 1.1× 55 0.3× 72 0.4× 79 1.4k
Stephen D. Wise Singapore 16 244 0.8× 168 0.6× 104 0.5× 228 1.3× 163 1.0× 29 985
N. Rietbrock Germany 19 218 0.7× 361 1.3× 147 0.8× 231 1.3× 196 1.2× 147 1.4k
Dolores Ochoa Spain 25 548 1.8× 207 0.8× 273 1.4× 94 0.5× 100 0.6× 98 1.6k

Countries citing papers authored by C Adithan

Since Specialization
Citations

This map shows the geographic impact of C Adithan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C Adithan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C Adithan more than expected).

Fields of papers citing papers by C Adithan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C Adithan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C Adithan. The network helps show where C Adithan may publish in the future.

Co-authorship network of co-authors of C Adithan

This figure shows the co-authorship network connecting the top 25 collaborators of C Adithan. A scholar is included among the top collaborators of C Adithan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C Adithan. C Adithan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rani, Jyoti, Sandeep Grover, Puneet Talwar, et al.. (2019). Global Text Mining and Development of Pharmacogenomic Knowledge Resource for Precision Medicine. Frontiers in Pharmacology. 10. 839–839. 7 indexed citations
2.
Shewade, Deepak Gopal, et al.. (2016). Serotonin transporter gene (SLC6A4) polymorphisms are associated with response to fluoxetine in south Indian major depressive disorder patients. European Journal of Clinical Pharmacology. 72(10). 1215–1220. 22 indexed citations
3.
Adithan, C. (2014). Drug - drug interactions for therapeutic biologics. SHILAP Revista de lepidopterología. 14 indexed citations
4.
Shewade, Deepak Gopal, et al.. (2013). Genetic variation and haplotype structure of the gene Vitamin K epoxide reductase complex, subunit 1 in the Tamilian population. Journal of Pharmacology and Pharmacotherapeutics. 4(1). 53–58. 7 indexed citations
5.
Pal, G K, et al.. (2013). Preference for salt contributes to sympathovagal imbalance in the genesis of prehypertension. European Journal of Clinical Nutrition. 67(6). 586–591. 9 indexed citations
6.
Pal, G K, C Adithan, P. H. Ananthanarayanan, et al.. (2013). Effects of Gender on Sympathovagal Imbalance, Prehypertension Status, and Cardiovascular Risks in First-Degree Relatives of Type 2 Diabetics. American Journal of Hypertension. 27(3). 317–324. 15 indexed citations
7.
Adithan, C, et al.. (2012). Medication error - Inadvertent high dose intradermal cloxacillin induced skin necrosis. Indian Journal of Pharmacology. 44(1). 122–122. 1 indexed citations
8.
Pal, G K, et al.. (2011). Assessment of Sympathovagal Imbalance By Spectral Analysis of Heart Rate Variability in Prehypertensive and Hypertensive Patients in Indian Population. Clinical and Experimental Hypertension. 33(7). 478–483. 48 indexed citations
9.
Adithan, C, et al.. (2010). Atropine-induced rhabdomyolysis. Journal of Postgraduate Medicine. 56(1). 42–43. 7 indexed citations
10.
Balachander, J., et al.. (2009). Cholesteryl ester transfer protein TaqIB, −629C>A and I405V polymorphisms and risk of coronary heart disease in an Indian population. Clinica Chimica Acta. 402(1-2). 139–145. 22 indexed citations
11.
Adithan, C, et al.. (2006). Influence of the CYP2C9 AND CYP2C19 polymorphisms on phenytoin hydroxylation in healthy individuals from south India.. PubMed. 123(5). 665–70. 36 indexed citations
12.
13.
Adithan, C, et al.. (2003). Genotype and allele frequency of CYP2D6 in Tamilian population. European Journal of Clinical Pharmacology. 59(7). 517–520. 15 indexed citations
14.
Adithan, C, et al.. (2000). Effect of two types of Indian breakfast on bioavailability of cefuroxime axetil.. PubMed. 112. 104–8. 6 indexed citations
15.
Abraham, Klaus, et al.. (2000). Review of endocrine pharmacology.. Indian Journal of Pharmacology. 32(4). 4 indexed citations
16.
Adithan, C, et al.. (2000). Status report on chemotherapeutic agents.. Indian Journal of Pharmacology. 32(4).
17.
Adithan, C, et al.. (1992). Pharmacokinetics of ciprofloxacin - limitation to salivary and urinary sampling. Indian Journal of Pharmacology. 24(1). 25. 4 indexed citations
18.
Adithan, C, et al.. (1990). Increased elimination of phenytoin in type I undernourished diabetic patients. Indian Journal of Pharmacology. 22(4). 211. 2 indexed citations
19.
Adithan, C, et al.. (1988). Effect of type i diabetes mellitus on theophylline elimination. Medical science research. 16(8). 427–428. 3 indexed citations
20.
Adithan, C, et al.. (1988). EFFECT OF DIABETES MELLITUS ON SALIVARY PARACETAMOL ELIMINATION. Clinical and Experimental Pharmacology and Physiology. 15(6). 465–471. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026